Insider Buy/Sell Details for the Healthcare Sector — February 2026
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (1586)
Jazz Pharmaceuticals plc (JAZZ)
Patil Neena M — EVP & Chief Legal Officer
Shares
1,061
Price
$190.00
Total Value
$201.59K
Shares Held After
62,357
% of Holdings
1.7%
Jazz Pharmaceuticals plc (JAZZ)
Patil Neena M — EVP & Chief Legal Officer
Shares
3,523
Price
$193.58
Total Value
$681.99K
Shares Held After
63,418
% of Holdings
5.3%
Jazz Pharmaceuticals plc (JAZZ)
Patil Neena M — EVP & Chief Legal Officer
Shares
11,529
Price
$191.65
Total Value
$2.21M
Shares Held After
66,941
% of Holdings
14.7%
Jazz Pharmaceuticals plc (JAZZ)
Patil Neena M — EVP & Chief Legal Officer
Shares
2,916
Price
$189.81
Total Value
$553.49K
Shares Held After
68,391
% of Holdings
4.1%
Jazz Pharmaceuticals plc (JAZZ)
Patil Neena M — EVP & Chief Legal Officer
Shares
15,555
Price
$190.28
Total Value
$2.96M
Shares Held After
68,391
% of Holdings
18.5%
Jazz Pharmaceuticals plc (JAZZ)
Patil Neena M — EVP & Chief Legal Officer
Shares
875
Price
$192.07
Total Value
$168.06K
Shares Held After
56,862
% of Holdings
1.5%
Jazz Pharmaceuticals plc (JAZZ)
Patil Neena M — EVP & Chief Legal Officer
Shares
16,602
Price
$192.53
Total Value
$3.20M
Shares Held After
56,862
% of Holdings
22.6%
LEMAITRE VASCULAR INC (LMAT)
LeMaitre George W — Director
Shares
150,000
Price
$106.76
Total Value
$16.01M
Shares Held After
1,532,304
% of Holdings
8.9%
Privia Health Group, Inc. (PRVA)
Morris Matthew Shawn — Director
Shares
7,788
Price
$24.99
Total Value
$194.62K
Shares Held After
68,188
% of Holdings
10.3%
Nuvalent, Inc. (NUVL)
Noci Darlene — Chief Development Officer
Shares
200
Price
$104.25
Total Value
$20.85K
Shares Held After
58,117
% of Holdings
0.3%
Nuvalent, Inc. (NUVL)
Noci Darlene — Chief Development Officer
Shares
2,300
Price
$103.44
Total Value
$237.91K
Shares Held After
58,317
% of Holdings
3.8%
Nuvalent, Inc. (NUVL)
Noci Darlene — Chief Development Officer
Shares
3,000
Price
$102.64
Total Value
$307.92K
Shares Held After
60,617
% of Holdings
4.7%
TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA)
Kalif Eliyahu Sharon — EVP, Chief Financial Officer
Shares
345,810
Price
$33.64
Total Value
$11.63M
Shares Held After
57,478
% of Holdings
85.7%
Jazz Pharmaceuticals plc (JAZZ)
Henderson Mary Elizabeth — SVP, Technical Operations
Shares
5,343
Price
$194.49
Total Value
$1.04M
Shares Held After
28,728
% of Holdings
15.7%
AMGEN INC (AMGN)
Santos Esteban — EVP, Operations
Shares
24,291
Price
$379.12
Total Value
$9.21M
Shares Held After
76,618
% of Holdings
24.1%
AMGEN INC (AMGN)
Santos Esteban — EVP, Operations
Shares
30,501
Price
$379.12
Total Value
$11.56M
Shares Held After
76,618
% of Holdings
28.5%
IDEXX LABORATORIES INC /DE (IDXX)
MAZELSKY JONATHAN JAY — Director
Shares
2,589
Price
$663.04
Total Value
$1.72M
Shares Held After
83,606
% of Holdings
3.0%
IDEXX LABORATORIES INC /DE (IDXX)
MAZELSKY JONATHAN JAY — Director
Shares
1,000
Price
$662.16
Total Value
$662.16K
Shares Held After
86,195
% of Holdings
1.1%
IDEXX LABORATORIES INC /DE (IDXX)
MAZELSKY JONATHAN JAY — Director
Shares
1,200
Price
$661.10
Total Value
$793.32K
Shares Held After
87,195
% of Holdings
1.4%
IDEXX LABORATORIES INC /DE (IDXX)
MAZELSKY JONATHAN JAY — Director
Shares
2,859
Price
$659.75
Total Value
$1.89M
Shares Held After
88,395
% of Holdings
3.1%
IDEXX LABORATORIES INC /DE (IDXX)
MAZELSKY JONATHAN JAY — Director
Shares
3,660
Price
$658.92
Total Value
$2.41M
Shares Held After
91,254
% of Holdings
3.9%
IDEXX LABORATORIES INC /DE (IDXX)
MAZELSKY JONATHAN JAY — Director
Shares
2,860
Price
$657.84
Total Value
$1.88M
Shares Held After
94,914
% of Holdings
2.9%
IDEXX LABORATORIES INC /DE (IDXX)
MAZELSKY JONATHAN JAY — Director
Shares
1,343
Price
$656.85
Total Value
$882.14K
Shares Held After
97,774
% of Holdings
1.4%
IDEXX LABORATORIES INC /DE (IDXX)
MAZELSKY JONATHAN JAY — Director
Shares
1,488
Price
$655.85
Total Value
$975.90K
Shares Held After
99,117
% of Holdings
1.5%
IDEXX LABORATORIES INC /DE (IDXX)
MAZELSKY JONATHAN JAY — Director
Shares
1,111
Price
$654.63
Total Value
$727.29K
Shares Held After
100,605
% of Holdings
1.1%
IDEXX LABORATORIES INC /DE (IDXX)
MAZELSKY JONATHAN JAY — Director
Shares
1,171
Price
$653.68
Total Value
$765.45K
Shares Held After
101,716
% of Holdings
1.1%
IDEXX LABORATORIES INC /DE (IDXX)
MAZELSKY JONATHAN JAY — Director
Shares
1,669
Price
$652.49
Total Value
$1.09M
Shares Held After
102,887
% of Holdings
1.6%
IDEXX LABORATORIES INC /DE (IDXX)
MAZELSKY JONATHAN JAY — Director
Shares
1,095
Price
$651.49
Total Value
$713.38K
Shares Held After
104,556
% of Holdings
1.0%
IDEXX LABORATORIES INC /DE (IDXX)
MAZELSKY JONATHAN JAY — Director
Shares
1,281
Price
$650.67
Total Value
$833.51K
Shares Held After
105,651
% of Holdings
1.2%
AdaptHealth Corp. (AHCO)
Rew Richard W. II — CLO and General Counsel
Shares
5,000
Price
$8.91
Total Value
$44.55K
Shares Held After
107,097
% of Holdings
4.7%
MYRIAD GENETICS INC (MYGN)
Phanstiel S. Louise — Director
Shares
50,407
Price
$4.80
Total Value
$242.10K
Shares Held After
233,951
% of Holdings
21.5%
AbCellera Biologics Inc. (ABCL)
Thermopylae Holdings Ltd. — 10% Owner
Shares
177,457
Price
$3.27
Total Value
$580.28K
Shares Held After
56,096,097
% of Holdings
0.3%
HENRY SCHEIN INC (HSIC)
BERGMAN STANLEY M — Director
Shares
7,212
Price
$81.51
Total Value
$587.85K
Shares Held After
427,615
% of Holdings
1.7%
HENRY SCHEIN INC (HSIC)
BERGMAN STANLEY M — Director
Shares
31,134
Price
$80.90
Total Value
$2.52M
Shares Held After
434,827
% of Holdings
6.7%
BridgeBio Pharma, Inc. (BBIO)
Apuli Maricel — Chief Accounting Officer
Shares
2,000
Price
$66.00
Total Value
$132.00K
Shares Held After
121,945
% of Holdings
1.6%
Wave Life Sciences Ltd. (WVE)
Francis Chris — SVP, Corporate Development, Head of Emerging Areas
Shares
15,294
Price
$15.00
Total Value
$229.41K
Shares Held After
61,867
% of Holdings
19.8%
Wave Life Sciences Ltd. (WVE)
Francis Chris — SVP, Corporate Development, Head of Emerging Areas
Shares
17,900
Price
$15.09
Total Value
$270.18K
Shares Held After
61,867
% of Holdings
22.4%
Axsome Therapeutics, Inc. (AXSM)
Coleman Mark — Director
Shares
25,000
Price
$161.11
Total Value
$4.03M
Shares Held After
47,140
% of Holdings
34.7%
Axsome Therapeutics, Inc. (AXSM)
Jacobson Mark L. — Chief Operating Officer
Shares
35,378
Price
$161.88
Total Value
$5.73M
Shares Held After
0
% of Holdings
100.0%
BECTON DICKINSON & CO (BDX)
Feld Michael — EVP, Chief Revenue Officer
Shares
75
Price
$181.84
Total Value
$13.64K
Shares Held After
21,308
% of Holdings
0.4%
IDEXX LABORATORIES INC /DE (IDXX)
Hunt Nimrata — Executive Vice President
Shares
2,693
Price
$661.54
Total Value
$1.78M
Shares Held After
19,899
% of Holdings
11.9%
Neuronetics, Inc. (STIM)
Sullivan Keith J — Director
Shares
8,452
Price
$1.35
Total Value
$11.41K
Shares Held After
1,524,713
% of Holdings
0.6%
Neuronetics, Inc. (STIM)
MACAN WILLIAM ANDREW — EVP, CLO and CS
Shares
3,427
Price
$1.35
Total Value
$4.63K
Shares Held After
880,134
% of Holdings
0.4%
Climb Bio, Inc. (CLYM)
Thomas Stephen Basil — Director
Shares
16,313
Price
$7.01
Total Value
$114.29K
Shares Held After
154,657
% of Holdings
9.5%
NewAmsterdam Pharma Co N.V. (NAMS)
Davidson Michael H. — Director
Shares
17,924
Price
$34.44
Total Value
$617.30K
Shares Held After
174,144
% of Holdings
9.3%
NewAmsterdam Pharma Co N.V. (NAMS)
Davidson Michael H. — Director
Shares
165,408
Price
$33.63
Total Value
$5.56M
Shares Held After
477,783
% of Holdings
25.7%
BIOMARIN PHARMACEUTICAL INC (BMRN)
Davis George Eric — EVP, Chief Legal Officer
Shares
26,061
Price
$61.36
Total Value
$1.60M
Shares Held After
72,453
% of Holdings
26.5%
BIOMARIN PHARMACEUTICAL INC (BMRN)
Friberg Gregory R — EVP, Chief R&D Officer
Shares
6,326
Price
$60.38
Total Value
$381.94K
Shares Held After
37,578
% of Holdings
14.4%
PHIBRO ANIMAL HEALTH CORP (PAHC)
BENDHEIM JACK — Director
Shares
711
Price
$54.28
Total Value
$38.59K
Shares Held After
1,480
% of Holdings
32.5%
PHIBRO ANIMAL HEALTH CORP (PAHC)
BENDHEIM JACK — Director
Shares
6,329
Price
$53.67
Total Value
$339.67K
Shares Held After
2,191
% of Holdings
74.3%
Showing 101–150 of 1586 transactions (page 3 of 32)